New MDCG Guidance on Updating the European Medical Device Nomenclature (EMDN)
- Home
- regulatory updates
- New MDCG Guidance on Updating the European Medical Device Nomenclature (EMDN)
New MDCG Guidance on Updating the European Medical Device Nomenclature (EMDN)
Friday, 15 March 2024
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
The Medical Device Coordination Group (MDCG) released a procedure for the updates of the European Medical Device Nomenclature (EMDN). The EMDN, as established by Article 26 of Regulation (EU) 2017/745 – MDR and Article 23 of Regulation (EU) 2017/746 - IVDR, will be annually reviewed and updated based on the practical use of the EMDN and feedback from its users (MDCG 2024-02).
.jpg?width=1536&height=864&name=New%20MDCG%20Guidance%20on%20Updating%20the%20European%20Medical%20Device%20Nomenclature%20(EMDN).jpg)
On February 6th, 2024, the Medical Device Coordination Group (MDCG) released a procedure for the updates of the European Medical Device Nomenclature (EMDN). The EMDN, as established by Article 26 of Regulation (EU) 2017/745 – Medical Device Regulation (MDR) and Article 23 of Regulation (EU) 2017/746 – In Vitro Diagnostic medical devices Regulation (IVDR), will be annually reviewed and updated based on the practical use of the EMDN and feedback from its users (MDCG 2024-02).
MDCG 2024-02 – Procedures for the updates of the European Medical Device Nomenclature.
This document lays out the procedures for the annual revision as well as the procedure for ad-hoc requests requiring an expedited review.
Annual review
- Actor involved are the MDCG Nomenclature working group, the EMDN Technical team or EMDN-TT and the users
- The procedure for the annual revision is in 4 phases
- Phase I: collection of requests (January)
- Phase II: Evaluation of requests and analysis of practical use (February-July)
- Phase III: Validation and endorsement (August -October)
- Phase IV: MDCG endorsement and publication (November -December)
Pilot procedure for ad-hoc updates
- Only requests submitted by the competent authority and the notified bodies qualify under the ad-hoc procedure
- Only new codes requests may be submitted
What Does This Mean To You?
MDCG 2024-02 provides insights in the process how the EMDN remains up to date and how ad-hoc requests can be done.
Discover more expert content
Previous
Regulatory Affairs
27 Jun 2024
Urogynaecological Surgical Mesh Implants for Pelvic Organ Prolapse and Stress Urinary Incontinence Repair (MDCG 2024-1-5)
MDCG 2024-1-5 – DSVG 05 – Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse...
Regulatory Affairs
15 Nov 2024
MDCG 2023-3 Rev 1 released
On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...
Regulatory Affairs
17 Dec 2025
MHRA publishes new IVD Roadmap
The roadmap sets out broad timelines and planned activities across three key themes:
Regulatory Affairs
12 Dec 2024
New MDCG 2024-16 form released
On December 6th, 2024, the Medical Device Coordination Group (MDCG) released a Manufacturer...
Regulatory Affairs
23 Jun 2025
4 key guidance documents released under the EU MDR and IVDR frameworks
MDCG 2025-5 clarifies essential aspects of IVD performance studies, including study types, sponsor...
Regulatory Affairs
27 Jun 2024
Urogynaecological Surgical Mesh Implants for Pelvic Organ Prolapse and Stress Urinary Incontinence Repair (MDCG 2024-1-5)
MDCG 2024-1-5 – DSVG 05 – Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse...
Regulatory Affairs
15 Nov 2024
MDCG 2023-3 Rev 1 released
On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...
Regulatory Affairs
17 Dec 2025
MHRA publishes new IVD Roadmap
The roadmap sets out broad timelines and planned activities across three key themes:
Regulatory Affairs
12 Dec 2024
New MDCG 2024-16 form released
On December 6th, 2024, the Medical Device Coordination Group (MDCG) released a Manufacturer...
Regulatory Affairs
23 Jun 2025
4 key guidance documents released under the EU MDR and IVDR frameworks
MDCG 2025-5 clarifies essential aspects of IVD performance studies, including study types, sponsor...
Regulatory Affairs
27 Jun 2024
Urogynaecological Surgical Mesh Implants for Pelvic Organ Prolapse and Stress Urinary Incontinence Repair (MDCG 2024-1-5)
MDCG 2024-1-5 – DSVG 05 – Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse...
Regulatory Affairs
15 Nov 2024
MDCG 2023-3 Rev 1 released
On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe